Nutrien (NYSE:NTR – Get Free Report) had its price objective hoisted by equities research analysts at BMO Capital Markets from $75.00 to $85.00 in a research report issued on Friday,BayStreet.CA reports. The firm presently has an “outperform” rating on the stock. BMO Capital Markets’ target price would suggest a potential upside of 19.40% from the stock’s current price.
Several other research firms also recently commented on NTR. Royal Bank Of Canada upped their price objective on shares of Nutrien from $70.00 to $75.00 and gave the company an “outperform” rating in a report on Tuesday, January 20th. Zacks Research upgraded shares of Nutrien from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 27th. Bank of America increased their price target on shares of Nutrien from $64.00 to $71.00 and gave the company a “neutral” rating in a report on Friday. Oppenheimer restated an “outperform” rating on shares of Nutrien in a report on Tuesday, January 27th. Finally, UBS Group upped their target price on Nutrien from $58.00 to $63.00 and gave the company a “neutral” rating in a research report on Monday, January 12th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $70.11.
Read Our Latest Stock Report on Nutrien
Nutrien Stock Performance
Nutrien (NYSE:NTR – Get Free Report) last posted its earnings results on Wednesday, February 18th. The company reported $0.83 earnings per share for the quarter, missing analysts’ consensus estimates of $0.87 by ($0.04). Nutrien had a return on equity of 8.46% and a net margin of 8.43%.The business had revenue of $5.12 billion for the quarter, compared to analyst estimates of $5.26 billion. During the same period in the previous year, the firm posted $0.31 earnings per share. The firm’s revenue was up 5.1% compared to the same quarter last year. On average, equities research analysts expect that Nutrien will post 3.72 earnings per share for the current year.
Institutional Investors Weigh In On Nutrien
Several institutional investors have recently made changes to their positions in NTR. Wellington Management Group LLP grew its position in Nutrien by 440.2% during the fourth quarter. Wellington Management Group LLP now owns 16,338,606 shares of the company’s stock worth $1,008,713,000 after buying an additional 13,313,817 shares in the last quarter. Norges Bank bought a new stake in shares of Nutrien during the 2nd quarter valued at $395,842,000. Arrowstreet Capital Limited Partnership grew its holdings in shares of Nutrien by 48.5% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 11,944,730 shares of the company’s stock worth $696,058,000 after purchasing an additional 3,900,755 shares in the last quarter. Boston Partners acquired a new stake in shares of Nutrien during the 2nd quarter worth $150,416,000. Finally, First Eagle Investment Management LLC increased its position in shares of Nutrien by 14.0% in the second quarter. First Eagle Investment Management LLC now owns 13,268,229 shares of the company’s stock worth $772,742,000 after purchasing an additional 1,627,328 shares during the period. 63.10% of the stock is currently owned by institutional investors.
Nutrien News Roundup
Here are the key news stories impacting Nutrien this week:
- Positive Sentiment: Multiple broker upgrades and higher price targets — BMO raised its target to $85 (outperform), JPMorgan to $78 (overweight), Wells Fargo to $77 (equal weight) and Raymond James to $74, signaling analyst confidence in Nutrien’s outlook and suggesting meaningful upside from recent levels. BayStreet.CA Benzinga
- Positive Sentiment: Shareholder returns: Nutrien raised its quarterly dividend (to $0.55) and announced a new buyback program — a direct positive for investors seeking yield and capital return. TipRanks
- Positive Sentiment: Favorable commodity outlook: Management expects stronger global potash demand in 2026 despite difficult farm economics — a revenue/volume tailwind for Nutrien’s fertilizer segment. Reuters
- Neutral Sentiment: Earnings materials available — full Q4 2025 call transcript and presentation have been published for investor review; useful for drilling into segment-level detail but not a directional catalyst by itself. Seeking Alpha Yahoo Finance
- Neutral Sentiment: Some analysts remain cautious: Bank of America raised its target to $71 but kept a neutral rating (minimal implied upside). That tempers the bullish momentum from higher targets. Benzinga
- Negative Sentiment: Operational results missed consensus: Q4 EPS came in at $0.83 vs. $0.87 expected and revenue of ~$5.12B was slightly below estimates — the earnings miss is the primary near-term negative pressure on the share price. Zacks
- Negative Sentiment: Mixed analyst views persist — UBS assigned a “hold,” which indicates some investors and brokers are reserving judgment despite the positive catalysts. Globe & Mail
About Nutrien
Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.
Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.
Further Reading
- Five stocks we like better than Nutrien
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- How a Family Trust May Be Able To Help Preserve Your Wealth
- This makes me furious
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.
